For U.S. residents only. Non-U.S. residents Novartis Pharma US
Learn About Novartis
   
Learn About Clinical Trials
                                   
Study Participation


Participation Advantages
Participation in this Trial

Participation in a clinical study such as SIG-NET will offer you a chance to receive investigational therapy specifically for your illness. However, you must be aware that it is possible you will not benefit from this treatment.

What is the time commitment for patients in this study?

The total duration of the study treatment will be 6 months. All patients will have safety follow-up visits after they have received their last injection.

What should I expect while taking SOM230?

Your doctors and nurses will monitor you closely while you are in this study. You will be asked to call your patient diary (interactive voice response system) each day and return to your doctor’s office regularly so he or she can see how you’re doing and record your progress. If necessary, you are free to withdraw from the study or be withdrawn by your doctor at any time.

The most frequently reported side effects are stomach related, most commonly diarrhea, nausea, and abdominal pain. As with any medication, side effects vary from person to person. Many symptoms go away shortly after SOM230 is stopped but in some cases they may be serious and/or long-lasting. Remember to report any symptoms to your doctor or nurse.

How is the treatment administered?

All injections of long-acting release (LAR) study drug will be given by an independent study nurse. Patients may be asked to self-administer the study drug via subcutaneous (s.c.) injections as prescribed by the site staff or investigator.

How will I know if the treatment is working?

Throughout the study period you will be involved in numerous evaluations. Your doctor will assess your progress every step of the way through various examinations and testing. He or she will keep you informed of your status. Feel free to ask your doctor any questions you may have.

Who will pay for the study?

Novartis will pay for all study-specific assessments.

To find out if you are eligible to participate in the SIG-NET research study, click the link below.

Click here to see if you Qualify 

To view all Novartis clinical trials recruiting in the U.S., visit NovartisClinicalTrials.com

 

Novartis Pharma US